OverviewSuggest Edit

India Globalization Capital is developing a product portfolio of phytocannabinoid-based therapies through leading edge research for the treatment of a wide range of therapeutic indications. These include neuropathic and cancer pain, epilepsy, end of life supportive care, adjunctive supportive therapies of chronic neurological and oncological diagnosis, which are life altering or life threatening. 
The company's mission is to treat pain, PTSD, seizures, cachexia, chronic and terminal neurological and oncological diagnoses, and other life altering conditions with phytocannabinoid-based treatments.
TypePublic
Founded2005
HQBethesda, US
Websiteigcinc.us

Latest Updates

Employees (est.) (Mar 2019)20(+25%)
Revenue (FY, 2019)$5.1 M(+134%)
Share Price (Jan 2020)$0.7 (-5%)

India Globalization Capital Office Locations

India Globalization Capital has an office in Bethesda
Bethesda, US (HQ)
Bethesda, MD, USA
Show all (1)

India Globalization Capital Financials and Metrics

India Globalization Capital Revenue

Embed Graph
View revenue for all periods
India Globalization Capital's revenue was reported to be $5.12 m in FY, 2019
USD

Revenue (Q2, 2020)

1.8m

Gross profit (Q2, 2020)

28.0k

Gross profit margin (Q2, 2020), %

1.5%

Net income (Q2, 2020)

(1.2m)

EBIT (Q2, 2020)

(1.3m)

Market capitalization (10-Jan-2020)

25.9m

Closing stock price (10-Jan-2020)

0.7

Cash (30-Sept-2019)

14.1m

EV

11.9m
India Globalization Capital's current market capitalization is $25.9 m.
Annual
USDFY, 2012FY, 2013FY, 2014FY, 2015FY, 2016FY, 2017FY, 2018FY, 2019

Revenue

4.2m8.0m2.3m7.7m6.4m580.4k2.2m5.1m

Cost of goods sold

4.8m6.5m1.9m7.1m5.5m362.1k2.1m5.0m

Gross profit

(618.4k)1.5m381.6k579.7k843.3k218.2k81.5k132.0k

Gross profit Margin, %

(15%)19%17%8%13%38%4%3%
USDY, 2019

EV/EBIT

-9.2 x

EV/CFO

-2.7 x

Financial Leverage

1.1 x
Show all financial metrics

India Globalization Capital Online and Social Media Presence

Embed Graph

India Globalization Capital News and Updates

India Globalization Capital says it will re-list on NYSE American exchange

India Globalization Capital Inc. said late Thursday that it had successfully challenged the NYSE American's Oct. 29 decision to de-list the stock. IGC said it will re-list no later than Feb. 26. "We are very pleased that the Exchange procedures allowed us the opportunity to challenge the decision t…

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in India Globalization Capital, Inc. of Class Action Lawsuit and Upcoming Deadline - IGC; IGCC

NEW YORK, Dec. 21, 2018 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against India Globalization Capital, Inc. ("India Globalization" or the "Company") (NYSE: IGC)(OTCMKTS: IGCC) and certain of its officers. The class action, filed in United States...

LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In India Globalization Capital, Inc. To Contact The Firm

NEW YORK, Nov. 7, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in India Globalization Capital, Inc. ("India Globalization" or the "Company") (formerly, NYSE:IGC) (Other OTC:IGC) of the January 2, 2019 deadline to seek the role of...

INDIA GLOBALIZATION INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In India Globalization Capital, Inc. To Contact The Firm

NEW YORK, Nov. 5, 2018 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against India Globalization Capital, Inc. ("India Globalization" or the "Company") (formerly, NYSE:IGC) (Other OTC:IGC). If you invested in India...

Questionable pot stock India Globalization Capital to have trading suspended

The NYSE American stock exchange said Monday that it will begin proceedings to delist the common stock of India Globalization Capital Inc. and that the company's common stock on the NYSE American will be suspended immediately because it has "substantially discontinued the business that it conducte…

Questionable pot company India Globalization Capital to have trading suspended

The NYSE American stock exchange said Monday that it will begin proceedings to delist the common stock of India Globalization Capital Inc. and that the company's common stock on the NYSE American will be suspended immediately because it has "substantially discontinued the business that it conducte…
Show more

India Globalization Capital Frequently Asked Questions

  • When was India Globalization Capital founded?

    India Globalization Capital was founded in 2005.

  • How many employees does India Globalization Capital have?

    India Globalization Capital has 20 employees.

  • What is India Globalization Capital revenue?

    Latest India Globalization Capital annual revenue is $5.1 m.

  • What is India Globalization Capital revenue per employee?

    Latest India Globalization Capital revenue per employee is $255.8 k.

  • Who are India Globalization Capital competitors?

    Competitors of India Globalization Capital include Attenua, LTS Lohmann Therapie-Systeme and KSQ Therapeutics.

  • Where is India Globalization Capital headquarters?

    India Globalization Capital headquarters is located at Bethesda, MD, USA, Bethesda.

  • Where are India Globalization Capital offices?

    India Globalization Capital has an office in Bethesda.

  • How many offices does India Globalization Capital have?

    India Globalization Capital has 1 office.